Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market by Product Type (Load-distributing Band Devices and Pneumatic Piston Devices), Power Source (Battery-operated and Electrically-operated), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing prevalence of cardiovascular diseases and increasing awareness and government initiative towards cardiovascular health.

The automatic mechanical cardiopulmonary resuscitation devices market was valued at USD 150.65 million in 2024, growing at a CAGR of 5.36% during the forecast period from 2025 to 2032 to reach USD 227.88 million by 2032. The demand for automatic mechanical cardiopulmonary resuscitation (CPR) devices is being driven by several key factors, including the rising prevalence of cardiovascular disease and cardiac arrest, primarily due to a growing geriatric population that is more susceptible to cardiac and respiratory failure. Increasing awareness, government initiatives focused on cardiovascular health, and ongoing technological advancements in CPR devices are creating a supportive environment for sustained market growth. These trends are expected to position the automatic mechanical CPR devices market for robust and steady expansion from 2025 to 2032.

Automatic Mechanical Cardiopulmonary Resuscitation Devices Market Dynamics:

According to the British Heart Foundation (2024), an estimated 640 million people worldwide were living with heart and circulatory conditions, a number that continues to rise due to the combined challenges of sedentary lifestyles and a rapidly aging population. Among the most prevalent cardiovascular diseases (CVDs) globally are coronary (ischemic) heart disease affecting over 250 million people (2022), peripheral arterial disease with approximately 110 million cases, stroke affecting nearly 94 million individuals, and atrial fibrillation impacting around 53 million people. The increasing burden of cardiovascular disease significantly elevates the risk of cardiac arrest, which requires immediate and effective intervention.

According to the National Institutes of Health (2023), more than 64 million people worldwide were affected by cardiac arrest in 2023 alone. This growing prevalence has led to heightened demand for automatic CPR (cardiopulmonary resuscitation) devices, which offer rapid, consistent, and efficient resuscitation, a critical procedure in improving survival rates during cardiac emergencies. Healthcare providers and emergency services are increasingly adopting automated CPR solutions to enhance treatment outcomes and reduce reliance on manual intervention. Therefore, rising cases of cardiovascular diseases and cardiac arrest are driving the automatic mechanical cardiopulmonary resuscitation (CPR) devices market growth.

Moreover, rising public awareness and supportive government initiatives are further propelling market growth. For instance, the World Health Organization (WHO), in collaboration with the U.S. Centers for Disease Control and Prevention (CDC), launched the Global Hearts Initiative in 2016 to assist governments in improving the prevention and control of CVDs. Similarly, the World Heart Federation promotes World Heart Day in the month of September each year to raise awareness of cardiovascular health.

Additionally, the rapidly aging global population is contributing significantly to market expansion. According to the United Nations (2023), the number of people aged 65 years and older was projected to more than double, from 761 million in 2021 to 1.6 billion by 2050. The population aged 80 and above was expected to grow at an even faster rate. As older adults are at higher risk for cardiac events, the demand for automated mechanical CPR devices is increasing, which is further propelling the market expansion.

Additionally, key market players are investing in R&D to develop advanced automatic CPR devices. For example, in April 2023, Defibtech announced the launch of the ARM XR, an advanced automated CPR device designed for use by emergency medical professionals in treating cardiac arrest. Such innovations and product launches are further driving the growth of the automatic mechanical CPR devices market.

However, the complications and safety concerns, such as device alignment, injury risk, equipment failure, and others associated with automatic mechanical CPR devices and lack of staff training and familiarity with equipment setup, among others, are some of the key constraints that may limit the growth of the automatic mechanical cardiopulmonary resuscitation (CPR) devices market.

Automatic Mechanical Cardiopulmonary Resuscitation Devices Market Segment Analysis:

Automatic Mechanical Cardiopulmonary Resuscitation (CPR) Devices Market by Product Type (Load-distributing Band Devices and Pneumatic Piston Devices), Power Source (Battery-operated and Electrically-operated), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the automatic mechanical cardiopulmonary resuscitation devices market, the load-distributing band devices category is estimated to account for the largest market share in 2024. The growth of the category is primarily driven by the increasing incidence of cardiac arrest cases worldwide, along with the numerous advantages and clinical applications offered by these devices in emergency cardiac care.

Load-distributing band (LDB) devices operate by applying circumferential chest compressions, which significantly reduce the risk of localized injuries to the ribs and internal organs. Compared to manual CPR or piston-driven alternatives, LDB devices offer a less traumatic resuscitation method while enhancing safety and efficacy.

These devices are designed to deliver consistent, high-quality compressions that help maintain optimal coronary and cerebral perfusion pressures, a critical procedure for improving survival outcomes during cardiac arrest. Furthermore, they ensure uninterrupted, uniform compressions at the recommended depth and rate (typically 100-120 compressions per minute), eliminating the inconsistencies caused by human fatigue, especially during prolonged resuscitation efforts where manual CPR performance often deteriorates.

A notable example in this category is the LUCAS 2® device by Stryker, which delivers automated chest compressions at a guideline-consistent depth of 5.3 cm (2.1 inches) and a rate of 102 compressions per minute. Its ability to maintain precise, uninterrupted compressions makes it a preferred choice among emergency medical professionals and hospitals worldwide.

Thus, the factors mentioned above are likely to boost the market segment and thereby increase the overall market of automatic mechanical cardiopulmonary resuscitation devices across the globe.

North America is expected to dominate the overall automatic mechanical cardiopulmonary resuscitation devices market:
North America is projected to hold the largest share of the automatic mechanical cardiopulmonary resuscitation devices market in 2024, driven by several key factors. This regional dominance is primarily attributed to the high prevalence of cardiovascular disease and heart failure, a rising geriatric population in the region. Additionally, the region benefits from a well-established healthcare infrastructure and the strong presence of leading market players, which further supports product adoption and accessibility. Collectively, these factors are positioning North America as the leading market in the global automatic mechanical cardiopulmonary resuscitation devices market.

According to the Centers for Disease Control and Prevention (CDC, 2024), in 2022, approximately 6.2 million adults in the U.S. were living with heart disease, a condition often associated with an increased risk of cardiac arrest. Similarly, data from the Government of Canada (2022), in 2022, 1 in 12 adults (approximately 2.6 million) aged 20 and over were diagnosed with heart disease in Canada. These rising cases of cardiovascular disease are a leading cause of cardiac arrest and have led to a growing reliance on automatic mechanical CPR devices, which help maintain blood circulation and oxygen delivery to vital organs until medical support becomes available.

According to the data from the Heart Failure Society of America (2024) projected that the number of Americans aged 20 and older living with heart failure will rise from 6.7 million in 2024 to 11.4 million by 2050, indicating a substantial increase in demand for effective resuscitation solutions like automated CPR systems. In Canada, the Heart and Stroke Foundation (2022) estimated that approximately 60,000 cardiac arrests occur annually, further underlining the critical need for automatic mechanical CPR devices.

As a result, the automatic mechanical CPR devices market in North America is experiencing notable growth, driven by the need for fast, reliable, and high-quality resuscitation in both pre-hospital and clinical settings. These devices provide consistent and uninterrupted chest compressions, reducing the limitations of manual CPR and improving survival rates during cardiac emergencies.

In addition to the medical need, government-led awareness initiatives are also contributing to market expansion. For example, Million Hearts®, a U.S. national initiative, aims to prevent one million heart attacks and strokes over five years by promoting evidence-based interventions to improve cardiovascular health. Likewise, the National Institutes of Health (NIH) observes American Heart Month every February, raising awareness about heart disease, the leading cause of death in the U.S. Such government initiatives and awareness are creating the demand for automatic mechanical CPR devices to prevent deaths due to cardiac arrest, thereby driving the market growth.

Collectively, the rising burden of cardiovascular disease, combined with government support to increase awareness about cardiovascular health and advanced healthcare infrastructure, is propelling the demand for automatic mechanical cardiopulmonary resuscitation devices in North America, reinforcing its position as a leading region in the global market.

Automatic Mechanical Cardiopulmonary Resuscitation Devices Market Key Players:

Some of the key market players operating in the automatic mechanical cardiopulmonary resuscitation devices market include Stryker, Asahi Kasei Corporation, Ambu A/S, Michigan Instruments, CPR Medical Devices, Inc., Zhuhai Kindway Medical Science & Technology Co., Ltd., Corpuls, Defibtech LLC, SCHILLER AG, Laerdal Medical, SunLife Science, and Ambulanc (Shenzhen) Tech. Co., Ltd., Henan Maisong Medical, Shenzhen Bangvo Technology Co., Ltd., NIHON KOHDEN CORPORATION, Koninklijke Philips N.V., BIOTRONIK, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., MEDIANA Co., Ltd., HeartSine Technologies, Ltd., and others.

Recent Developmental Activities in the Automatic Mechanical Cardiopulmonary Resuscitation Devices Market:

• In March 2025, ReNew Biomedical announced a partnership with Defibtech to provide service support for the Defibtech ARM XR device. Under this collaboration, ReNew Biomedical will handle distribution, basic maintenance, and repair services for the device, ensuring continued operational efficiency and customer support.

Key takeaways from the automatic mechanical cardiopulmonary resuscitation devices market report study

• Market size analysis for the current automatic mechanical cardiopulmonary resuscitation devices market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the automatic mechanical cardiopulmonary resuscitation devices market.
• Various opportunities available for the other competitors in the automatic mechanical cardiopulmonary resuscitation devices market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current automatic mechanical cardiopulmonary resuscitation devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the automatic mechanical cardiopulmonary resuscitation devices market growth in the future?

Target audience who can benefit from this automatic mechanical cardiopulmonary resuscitation devices market report study

• Automatic mechanical cardiopulmonary resuscitation device providers
• Research organizations and consulting companies
• Automatic mechanical cardiopulmonary resuscitation devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in automatic mechanical cardiopulmonary resuscitation devices
• Various end-users who want to know more about the automatic mechanical cardiopulmonary resuscitation devices market and the latest technological developments in the automatic mechanical cardiopulmonary resuscitation devices market.

Frequently Asked Questions for the Automatic Mechanical Cardiopulmonary Resuscitation Devices Market:

1. What are automatic mechanical cardiopulmonary resuscitation devices?

• Automatic mechanical cardiopulmonary resuscitation (CPR) devices are medical devices designed to deliver consistent, high-quality chest compressions automatically to a patient experiencing cardiac arrest. These devices are used to maintain blood circulation to the brain and vital organs when the heart has stopped beating, acting as a substitute for manual CPR.

2. What is the market for automatic mechanical cardiopulmonary resuscitation devices?

• The automatic mechanical cardiopulmonary resuscitation devices market was valued at USD 150.65 million in 2024, growing at a CAGR of 5.36% during the forecast period from 2025 to 2032 to reach USD 227.88 million by 2032.

3. What are the drivers for the automatic mechanical cardiopulmonary resuscitation devices market?

• The demand for automatic mechanical cardiopulmonary resuscitation (CPR) devices is being driven by several key factors, including the rising prevalence of cardiovascular disease and cardiac arrest, primarily due to a growing geriatric population that is more susceptible to cardiac and respiratory failure. Increasing awareness, government initiatives focused on cardiovascular health, and ongoing technological advancements in CPR devices are creating a supportive environment for sustained market growth. These trends are expected to position the automatic mechanical CPR devices market for robust and steady expansion from 2025 to 2032.

4. Who are the key players operating in the automatic mechanical cardiopulmonary resuscitation devices market?

• Some of the key market players operating in the automatic mechanical cardiopulmonary resuscitation devices market include Stryker, Asahi Kasei Corporation, Ambu A/S, Michigan Instruments, CPR Medical Devices, Inc., Zhuhai Kindway Medical Science & Technology Co., Ltd., corpuls, Defibtech LLC, SCHILLER AG, Laerdal Medical, SunLife Science, Ambulanc (Shenzhen) Tech. Co., Ltd., Henan Maisong Medical, Shenzhen Bangvo Technology Co., Ltd., NIHON KOHDEN CORPORATION, Koninklijke Philips N.V., BIOTRONIK, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., MEDIANA Co., Ltd., HeartSine Technologies, Ltd., and others.

5. Which region has the highest share in the automatic mechanical cardiopulmonary resuscitation devices market?

• North America is projected to hold the largest share of the automatic mechanical cardiopulmonary resuscitation devices market in 2024, driven by several key factors. This regional dominance is primarily attributed to the high prevalence of cardiovascular disease and heart failure, a rising geriatric population in the region. Additionally, the region benefits from a well-established healthcare infrastructure and the strong presence of leading market players, which further supports product adoption and accessibility. Collectively, these factors are positioning North America as the leading market in the global automatic mechanical cardiopulmonary resuscitation devices market.

This product will be delivered within 2 business days.